Nevro Corp.

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. The Nevro® Senza® SCS system received CE Mark in 2010, TGA Approval in 2011, FDA Approval in 2015, and is commercially available in Europe, Australia, and the United States.
Type
Public
HQ
Redwood City, US
Founded
2006
Size (employees)
308 (est)
Nevro Corp. was founded in 2006 and is headquartered in Redwood City, US

Nevro Corp. Office Locations

Nevro Corp. has office in Redwood City
Redwood City, US

Nevro Corp. Metrics

Nevro Corp. Summary

Market capitalization

$2.85 B

Closing share price

$94.3
Nevro Corp.'s current market capitalization is $2.85 B.

Nevro Corp. Financials

Nevro Corp.'s revenue is $69.6 M in FY, 2015 which is a 113.69% increase from the previous period.
FY, 2015FY, 2014

Revenue

$69.6 M$32.6 M

Net Income

$-67.4 M$-30.7 M

Nevro Corp. Market Value History

Nevro Corp. Online Presence

Nevro Corp. Company Life

You may also be interested in